[BMJ] Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behcet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial |
发布
回复
积分
70
30
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behcet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
30
Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis
30
How to interpret studies using Mendelian randomisation
